公司资料
PerkinElmer 股价、新闻与催化剂
- 股票代码:
- RVTY
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
116.17 USD (-0.57%)
收盘价
最后更新: 2026年8月17日
11.2B USD
市值
股价为何变动
As of Aug 17, 2026, RVTY closed down 0.57% at $116.17. No new same-company headline was identified in the current news window.
公司概览
业务概览
Revvity is a life sciences tools and diagnostics company with exposure to discovery, reproductive health, applied markets, and clinical testing. The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Revvity has a global footprint in life sciences tools and diagnostics. It sits in research and diagnostic infrastructure, not therapeutics.
商业模式特征
The company earns revenue from instruments, consumables, software, and diagnostic workflows. Investors focus on lab demand, prenatal and reproductive testing, and the health of research spending across its core markets.
生物医药行业定位
Revvity sits in the biotech tools layer and benefits from the broader life sciences spending cycle. It is less binary than a drug stock, but it remains important because research and diagnostics budgets drive demand.
未来催化剂
- Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。